Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (20) , 3391-3394
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (S2012010008130)
- Research Fund for the Doctoral Program of Higher Education of China (20124401110008)
- Natural Science Foundation of China (81402774)
This publication has 21 references indexed in Scilit:
- Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced CardiotoxicityJournal of Medicinal Chemistry, 2017
- C23 Steroids from the Venom of Bufo bufo gargarizansJournal of Natural Products, 2013
- Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPaseMolecular Cancer, 2013
- Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathwayCarcinogenesis, 2013
- Isolation and identification of phase I metabolites of resibufogenin in ratsXenobiotica, 2012
- Chemical Synthesis of the Cardiotonic Steroid Glycosides and Related Natural ProductsChemistry – A European Journal, 2012
- Bufadienolides and their antitumor activityNatural Product Reports, 2011
- New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizansSteroids, 2010
- Bufogargarizins A and B: Two Novel 19‐Norbufadienolides with Unprecedented Skeletons from the Venom of Bufo bufo gargarizansChemistry – A European Journal, 2010
- Stereoselective biotransformations using fungi as biocatalystsTetrahedron: Asymmetry, 2009